Caracterização nacional de doentes com DII (artigos publicados 1; 2; 3; 4; 5; 6)

BIOAZA - Impact of AZAthioprine in inducing and maintaining clinical, BIOmarkers and endoscopic remission among patients with Crohn's Disease: A 2-year longitudinal analysis from the GEDII registry. (Protocolo)

ATIB - Adjust Anti-TNF therapy in Inflammatory Bowel Disease. (Protocolo)

REMREGISTER - A study in the real-world practice to evaluate the impact of biosimilar infliximab (Remsima) in clinical outcomes in patients with inflammatory bowel diseases: a 2-year longitudinalanalysis from the GEDII Registry. (Protocolo)

SIMREGISTER - A study in the real-world practice to evaluate the impact of biosimilar infliximab (Inflectra) in clinical outcomes in patients with inflammatory bowel diseases: a 2-year longitudinal analysis from the GEDII Registry. (Protocolo)

MICRA - An epidemiological study to determine the prevalence of Microscopic Colitis and describe its clinical and histological features among patients with symptoms of chRonic watery diarrhea submitted to colonoscopy Attending to the Portuguese gastroenterology setting. (Protocolo)

PHDI - Padrões de hipermetilação na displasia no contexto de Doença Inflamatória Intestinal. (Protocolo)

ACERTIVE - Accuracy of calprotectin in evaluating sub-­‐clinical inflammation in Ulcerative Colitis. (Artigo)

CISAE - Correlation between IFX serum levels and anti-TNF antibody therapy (ATIs) in different pharmacokinetics times and endoscopic healing (Protocolo).

EASY - Early Surgery or Immunossupppresion (Protocolo).

HERICA – Histological and Endoscopic Evaluation of Remission Induced By Infliximab In Moderately To Severely Active Ulcerative Colitis Patients. (Artigo)

CAPOR - ESTUDO TRANSVERSAL DE AVALIAÇÃO DO NÚMERO DE CASOS DE ANEMIA EM DOENTES COM DII, EM PORTUGAL. (Artigo)

ATICA – (An Open Randomized Multicenter Clinical Investigation to Compare the Efficacy and Safety of Prednisone plus Adacolumn® GMA Apheresis versus Prednisone Alone in the Treatment of Patients with Mild or Moderately Active Steroid Dependent Ulcerative Colitis). (Artigo)
Coordenador para Portugal: Fernando Magro.

 
Agenda
De 22 de Setembro a 24 de Setembro de 2021 Terminal de Cruzeiros do Porto de Leixões - Porto
Reunião Anual GEDII
©2021 GEDII - Grupo de Estudos da Doença Inflamatória Intestinal | Todos os direitos reservados | Links úteis | Termos e condiçoes
Desenvolvido por DogmaSis